 | • レポートコード：GIR-22F19729 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Lisinopril Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のリシノプリルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 リシノプリル市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・2.5mg、5mg、10mg、20mg、30mg、40mg アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア 世界のリシノプリル市場の主要な市場プレーヤーは以下のとおりです。 ・Actavis Elizabeth、Apotex、Aurobindo Pharma、Ivax Pharmaceuticals、Lek Pharmaceuticals、Lupin、Mylan Pharmaceuticals、Ranbaxy Pharmaceuticals、Novartis、Teva Pharmaceuticals、Vintage Pharmaceuticals、Watson Laboratories、West Ward Pharmaceutical、Wockhardt、Merck Research Laboratories、Astrazeneca、Alvogen、Hikma、Prinston、Accord Hlthcare、CASI Pharms、Invagen Pharms、SUN Pharm 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、リシノプリル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なリシノプリルメーカーの企業概要、2019年～2022年までのリシノプリルの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なリシノプリルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別リシノプリルの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのリシノプリルのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのリシノプリル市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびリシノプリルの産業チェーンを掲載しています。 ・第13、14、15章では、リシノプリルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - リシノプリルの概要 - タイプ別分析（2017年vs2021年vs2028年）：2.5mg、5mg、10mg、20mg、30mg、40mg - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア - 世界のリシノプリル市場規模・予測 - 世界のリシノプリル生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Actavis Elizabeth、Apotex、Aurobindo Pharma、Ivax Pharmaceuticals、Lek Pharmaceuticals、Lupin、Mylan Pharmaceuticals、Ranbaxy Pharmaceuticals、Novartis、Teva Pharmaceuticals、Vintage Pharmaceuticals、Watson Laboratories、West Ward Pharmaceutical、Wockhardt、Merck Research Laboratories、Astrazeneca、Alvogen、Hikma、Prinston、Accord Hlthcare、CASI Pharms、Invagen Pharms、SUN Pharm ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：2.5mg、5mg、10mg、20mg、30mg、40mg ・アプリケーション別分析2017年-2028年：病院、ドラッグストア ・リシノプリルの北米市場分析 - リシノプリルの北米市場：タイプ別市場規模2017年-2028年 - リシノプリルの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・リシノプリルのヨーロッパ市場分析 - ：リシノプリルのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：リシノプリルのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・リシノプリルのアジア太平洋市場分析 - リシノプリルのアジア太平洋市場：タイプ別市場規模2017年-2028年 - リシノプリルのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・リシノプリルの南米市場分析 - リシノプリルの南米市場：タイプ別市場規模2017年-2028年 - リシノプリルの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・リシノプリルの中東・アフリカ市場分析 - リシノプリルの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - リシノプリルの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Lisinopril market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lisinopril market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lisinopril global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lisinopril include Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, and Lek Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lisinopril market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.5mg
5mg
10mg
20mg
30mg
40mg
Market segment by Application can be divided into
Hospital
Drug Store
The key market players for global Lisinopril market are listed below:
Actavis Elizabeth
Apotex
Aurobindo Pharma
Ivax Pharmaceuticals
Lek Pharmaceuticals
Lupin
Mylan Pharmaceuticals
Ranbaxy Pharmaceuticals
Novartis
Teva Pharmaceuticals
Vintage Pharmaceuticals
Watson Laboratories
West Ward Pharmaceutical
Wockhardt
Merck Research Laboratories
Astrazeneca
Alvogen
Hikma
Prinston
Accord Hlthcare
CASI Pharms
Invagen Pharms
SUN Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lisinopril product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lisinopril, with price, sales, revenue and global market share of Lisinopril from 2019 to 2022.
Chapter 3, the Lisinopril competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lisinopril breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lisinopril market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lisinopril.
Chapter 13, 14, and 15, to describe Lisinopril sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Lisinopril Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lisinopril Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Lisinopril Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size & Forecast
1.4.1 Global Lisinopril Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lisinopril Sales in Volume (2017-2028)
1.4.3 Global Lisinopril Price (2017-2028)
1.5 Global Lisinopril Production Capacity Analysis
1.5.1 Global Lisinopril Total Production Capacity (2017-2028)
1.5.2 Global Lisinopril Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lisinopril Market Drivers
1.6.2 Lisinopril Market Restraints
1.6.3 Lisinopril Trends Analysis
2 Manufacturers Profiles
2.1 Actavis Elizabeth
2.1.1 Actavis Elizabeth Details
2.1.2 Actavis Elizabeth Major Business
2.1.3 Actavis Elizabeth Lisinopril Product and Services
2.1.4 Actavis Elizabeth Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex Lisinopril Product and Services
2.2.4 Apotex Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Aurobindo Pharma
2.3.1 Aurobindo Pharma Details
2.3.2 Aurobindo Pharma Major Business
2.3.3 Aurobindo Pharma Lisinopril Product and Services
2.3.4 Aurobindo Pharma Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ivax Pharmaceuticals
2.4.1 Ivax Pharmaceuticals Details
2.4.2 Ivax Pharmaceuticals Major Business
2.4.3 Ivax Pharmaceuticals Lisinopril Product and Services
2.4.4 Ivax Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lek Pharmaceuticals
2.5.1 Lek Pharmaceuticals Details
2.5.2 Lek Pharmaceuticals Major Business
2.5.3 Lek Pharmaceuticals Lisinopril Product and Services
2.5.4 Lek Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Lisinopril Product and Services
2.6.4 Lupin Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan Pharmaceuticals
2.7.1 Mylan Pharmaceuticals Details
2.7.2 Mylan Pharmaceuticals Major Business
2.7.3 Mylan Pharmaceuticals Lisinopril Product and Services
2.7.4 Mylan Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ranbaxy Pharmaceuticals
2.8.1 Ranbaxy Pharmaceuticals Details
2.8.2 Ranbaxy Pharmaceuticals Major Business
2.8.3 Ranbaxy Pharmaceuticals Lisinopril Product and Services
2.8.4 Ranbaxy Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Lisinopril Product and Services
2.9.4 Novartis Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Lisinopril Product and Services
2.10.4 Teva Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Vintage Pharmaceuticals
2.11.1 Vintage Pharmaceuticals Details
2.11.2 Vintage Pharmaceuticals Major Business
2.11.3 Vintage Pharmaceuticals Lisinopril Product and Services
2.11.4 Vintage Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Watson Laboratories
2.12.1 Watson Laboratories Details
2.12.2 Watson Laboratories Major Business
2.12.3 Watson Laboratories Lisinopril Product and Services
2.12.4 Watson Laboratories Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 West Ward Pharmaceutical
2.13.1 West Ward Pharmaceutical Details
2.13.2 West Ward Pharmaceutical Major Business
2.13.3 West Ward Pharmaceutical Lisinopril Product and Services
2.13.4 West Ward Pharmaceutical Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Wockhardt
2.14.1 Wockhardt Details
2.14.2 Wockhardt Major Business
2.14.3 Wockhardt Lisinopril Product and Services
2.14.4 Wockhardt Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck Research Laboratories
2.15.1 Merck Research Laboratories Details
2.15.2 Merck Research Laboratories Major Business
2.15.3 Merck Research Laboratories Lisinopril Product and Services
2.15.4 Merck Research Laboratories Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Astrazeneca
2.16.1 Astrazeneca Details
2.16.2 Astrazeneca Major Business
2.16.3 Astrazeneca Lisinopril Product and Services
2.16.4 Astrazeneca Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Alvogen
2.17.1 Alvogen Details
2.17.2 Alvogen Major Business
2.17.3 Alvogen Lisinopril Product and Services
2.17.4 Alvogen Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Hikma
2.18.1 Hikma Details
2.18.2 Hikma Major Business
2.18.3 Hikma Lisinopril Product and Services
2.18.4 Hikma Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Prinston
2.19.1 Prinston Details
2.19.2 Prinston Major Business
2.19.3 Prinston Lisinopril Product and Services
2.19.4 Prinston Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Accord Hlthcare
2.20.1 Accord Hlthcare Details
2.20.2 Accord Hlthcare Major Business
2.20.3 Accord Hlthcare Lisinopril Product and Services
2.20.4 Accord Hlthcare Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 CASI Pharms
2.21.1 CASI Pharms Details
2.21.2 CASI Pharms Major Business
2.21.3 CASI Pharms Lisinopril Product and Services
2.21.4 CASI Pharms Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Invagen Pharms
2.22.1 Invagen Pharms Details
2.22.2 Invagen Pharms Major Business
2.22.3 Invagen Pharms Lisinopril Product and Services
2.22.4 Invagen Pharms Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 SUN Pharm
2.23.1 SUN Pharm Details
2.23.2 SUN Pharm Major Business
2.23.3 SUN Pharm Lisinopril Product and Services
2.23.4 SUN Pharm Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lisinopril Breakdown Data by Manufacturer
3.1 Global Lisinopril Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lisinopril Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lisinopril
3.4 Market Concentration Rate
3.4.1 Top 3 Lisinopril Manufacturer Market Share in 2021
3.4.2 Top 6 Lisinopril Manufacturer Market Share in 2021
3.5 Global Lisinopril Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lisinopril Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lisinopril Market Size by Region
4.1.1 Global Lisinopril Sales in Volume by Region (2017-2028)
4.1.2 Global Lisinopril Revenue by Region (2017-2028)
4.2 North America Lisinopril Revenue (2017-2028)
4.3 Europe Lisinopril Revenue (2017-2028)
4.4 Asia-Pacific Lisinopril Revenue (2017-2028)
4.5 South America Lisinopril Revenue (2017-2028)
4.6 Middle East and Africa Lisinopril Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lisinopril Sales in Volume by Type (2017-2028)
5.2 Global Lisinopril Revenue by Type (2017-2028)
5.3 Global Lisinopril Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lisinopril Sales in Volume by Application (2017-2028)
6.2 Global Lisinopril Revenue by Application (2017-2028)
6.3 Global Lisinopril Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lisinopril Sales by Type (2017-2028)
7.2 North America Lisinopril Sales by Application (2017-2028)
7.3 North America Lisinopril Market Size by Country
7.3.1 North America Lisinopril Sales in Volume by Country (2017-2028)
7.3.2 North America Lisinopril Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lisinopril Sales by Type (2017-2028)
8.2 Europe Lisinopril Sales by Application (2017-2028)
8.3 Europe Lisinopril Market Size by Country
8.3.1 Europe Lisinopril Sales in Volume by Country (2017-2028)
8.3.2 Europe Lisinopril Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lisinopril Sales by Type (2017-2028)
9.2 Asia-Pacific Lisinopril Sales by Application (2017-2028)
9.3 Asia-Pacific Lisinopril Market Size by Region
9.3.1 Asia-Pacific Lisinopril Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lisinopril Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lisinopril Sales by Type (2017-2028)
10.2 South America Lisinopril Sales by Application (2017-2028)
10.3 South America Lisinopril Market Size by Country
10.3.1 South America Lisinopril Sales in Volume by Country (2017-2028)
10.3.2 South America Lisinopril Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lisinopril Sales by Type (2017-2028)
11.2 Middle East & Africa Lisinopril Sales by Application (2017-2028)
11.3 Middle East & Africa Lisinopril Market Size by Country
11.3.1 Middle East & Africa Lisinopril Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lisinopril Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lisinopril and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lisinopril
12.3 Lisinopril Production Process
12.4 Lisinopril Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lisinopril Typical Distributors
13.3 Lisinopril Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer